
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

ZeroHarm Sciences recently raised Rs 65 crore to scale its innovative plant-based nutraceutical brand. Consequently, this capital infusion from Kotak Life Sciences Fund and Alkemi Growth Capital marks a major milestone. The company intends to enhance its research capabilities and global reach.
Specifically, ZeroHarm uses proprietary nano-formulation technology to increase the bioavailability of its supplements. This method ensures that herbal actives are absorbed more effectively by the body. Furthermore, the firm is building India's first \"Trust over Promise\" health platform. This model correlates supplement use with measurable diagnostic results.
Additionally, the startup plans to enter markets in the US, UK, and the Middle East. ZeroHarm maintains a vertically integrated ecosystem, covering extraction, R&D, and manufacturing. Notably, this structure allows for strict quality control and standardized health outcomes. Because of these factors, investors see high potential in the company’s science-led approach.
Q1: What is the \"Trust over Promise\" platform?
The \"Trust over Promise\" platform allows customers to see measurable health outcomes through before-and-after diagnostic testing.
Q2: How does nano-formulation technology benefit patients?
Nano-formulation breaks down herbal actives into ultra-fine particles, which significantly improves their absorption and efficacy compared to traditional supplements.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

ZeroHarm Sciences raised Rs 65 crore to expand its plant-based nutraceutical brand using nano-technology and a diagnostic-led health outcome model....
3 months ago

NBEMS has set a Guinness World Record for the most-viewed YouTube live stream of an AI healthcare training session, marking a milestone for Indian medical e...
3 months ago

RTI data reveals that Delhi utilized only 43% of its Rs 300-crore pollution control budget by Jan 2026, focusing largely on short-term mitigation measures....
3 months ago

The US ends health aid to Zimbabwe after talks on a $367M deal fail over data sharing. The move affects 1.2M people on HIV treatment and several health prog...
3 months ago

Researchers develop monoclonal antibodies to block Epstein-Barr virus while a new study finds significant microplastic levels in prostate tumor tissues....
3 months ago